Your browser doesn't support javascript.
loading
Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.
Lotta, Luca A; Sharp, Stephen J; Burgess, Stephen; Perry, John R B; Stewart, Isobel D; Willems, Sara M; Luan, Jian'an; Ardanaz, Eva; Arriola, Larraitz; Balkau, Beverley; Boeing, Heiner; Deloukas, Panos; Forouhi, Nita G; Franks, Paul W; Grioni, Sara; Kaaks, Rudolf; Key, Timothy J; Navarro, Carmen; Nilsson, Peter M; Overvad, Kim; Palli, Domenico; Panico, Salvatore; Quirós, Jose-Ramón; Riboli, Elio; Rolandsson, Olov; Sacerdote, Carlotta; Salamanca, Elena C; Slimani, Nadia; Spijkerman, Annemieke Mw; Tjonneland, Anne; Tumino, Rosario; van der A, Daphne L; van der Schouw, Yvonne T; McCarthy, Mark I; Barroso, Inês; O'Rahilly, Stephen; Savage, David B; Sattar, Naveed; Langenberg, Claudia; Scott, Robert A; Wareham, Nicholas J.
Afiliación
  • Lotta LA; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Sharp SJ; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Burgess S; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Perry JRB; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Stewart ID; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Willems SM; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Luan J; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Ardanaz E; Navarre Public Health Institute (ISPN), Pamplona, Spain.
  • Arriola L; Navarra Institute for Health Research (IdiSNA) Pamplona, Spain.
  • Balkau B; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.
  • Boeing H; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.
  • Deloukas P; Public Health Division of Gipuzkoa, San Sebastian, Spain.
  • Forouhi NG; Instituto BIO-Donostia, Basque Government, San Sebastian, Spain.
  • Franks PW; Inserm, CESP, U1018, Villejuif, France.
  • Grioni S; Inserm, CESP, U1018, Villejuif, France.
  • Kaaks R; German Institute of Human Nutrition Potsdam-Rehbruecke, Germany.
  • Key TJ; The Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
  • Navarro C; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Nilsson PM; Lund University, Malmö, Sweden.
  • Overvad K; Umeå University, Umeå, Sweden.
  • Palli D; Epidemiology and Prevention Unit, Milan, Italy.
  • Panico S; German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Quirós JR; University of Oxford, Oxford, United Kingdom.
  • Riboli E; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.
  • Rolandsson O; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
  • Sacerdote C; Unit of Preventive Medicine and Public Health, School of Medicine, University of Murcia, Spain.
  • Salamanca EC; Lund University, Malmö, Sweden.
  • Slimani N; Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
  • Spijkerman AM; Aalborg University Hospital, Aalborg, Denmark.
  • Tjonneland A; Cancer Research and Prevention Institute (ISPO), Florence, Italy.
  • Tumino R; Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
  • van der A DL; Public Health Directorate, Asturias, Spain.
  • van der Schouw YT; School of Public Health, Imperial College London, United Kingdom.
  • McCarthy MI; Umeå University, Umeå, Sweden.
  • Barroso I; Unit of Cancer Epidemiology, Citta' della Salute e della Scienza Hospital-University of Turin and Center for Cancer Prevention (CPO), Torino, Italy.
  • O'Rahilly S; Human Genetics Foundation (HuGeF), Torino, Italy.
  • Savage DB; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.
  • Sattar N; Andalusian School of Public Health, Granada, Spain.
  • Langenberg C; Instituto de Investigación Biosanitaria de Granada (Granada.ibs), Granada, Spain.
  • Scott RA; International Agency for Research on Cancer, Lyon, France.
  • Wareham NJ; National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
JAMA ; 316(13): 1383-1391, 2016 Oct 04.
Article en En | MEDLINE | ID: mdl-27701660
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Variación Genética / Enfermedad de la Arteria Coronaria / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Diabetes Mellitus Tipo 2 / LDL-Colesterol / Proteínas de la Membrana Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Systematic_reviews Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: JAMA Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Variación Genética / Enfermedad de la Arteria Coronaria / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Diabetes Mellitus Tipo 2 / LDL-Colesterol / Proteínas de la Membrana Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Systematic_reviews Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: JAMA Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido